The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Novikova M.V.

N.N. Blokhin Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

Rybko V.A.

N.N. Blokhin Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

Kochatkov A.V.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Khromova N.V.

N.N. Blokhin Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

Bogomazova S.Iu.

Lechebno-reabilitatsionnyĭ tsentr Ministerstva zdravookhraneniia i sotsial'nogo razvitiia RF, Moskva

Dugina V.B.

A.N. Belozersky Institute of Physicochemical Biology, Moscow State University, Moscow, Russia

Lyadov V.K.

Medical and Rehabilitation Center under the Ministry of Health of Russian Federation, Moscow, Russia

Kopnin P.B.

N.N. Blokhin Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

A change in the expression of membrane-associated proteins and cytoplasmic actin isoforms in the progression of human colon tumors

Authors:

Novikova M.V., Rybko V.A., Kochatkov A.V., Khromova N.V., Bogomazova S.Iu., Dugina V.B., Lyadov V.K., Kopnin P.B.

More about the authors

Read: 1977 times


To cite this article:

Novikova MV, Rybko VA, Kochatkov AV, et al. A change in the expression of membrane-associated proteins and cytoplasmic actin isoforms in the progression of human colon tumors. Russian Journal of Archive of Pathology. 2017;79(2):15‑21. (In Russ.)
https://doi.org/10.17116/patol201779215-21

Recommended articles:

References:

  1. Zeisberg M, Neilson E. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119(6):1429-1437. doi:10.1172/JCI36183
  2. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol. 1998;153(2):333-339. doi:10.1016/S0002-9440(10)65575-7
  3. Van Aken E, De Wever O, Correia da Rocha A, Mareel M. Defective E-cadherin/catenin complexes in human cancer. Virchows Arch. 2001;439(6):725-751. doi:10.1007/s004280100516
  4. Farmakovskaya M, Khromova N, Rybko V, Dugina V, Kopnin B, Kopnin P. E-Cadherin repression increases amount of cancer stem cells in human A549 lung adenocarcinoma and stimulates tumor growth. Cell Cycle. 2016;15(8):1084-1092. doi:10.1080/15384101.2016.1156268
  5. Farmakovskaya MD, Khromova NV, Kopnin BP, Kopnin PB. E-Cadherin repression increases amount of cancer stem cells and tumorigenic potential of human HCT116 colon adenocarcinoma cells. Rossiiskii bioterapevticheskii zhurnal. 2016;15(3):6-14. (In Russ.)
  6. Khromova N, Kopnin P, Rybko V, Kopnin B. Down-regulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms. Oncogene. 2012;31(11):1389-1397. doi:10.1038/onc.2011.330
  7. Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A, Kirchner T. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal- epithelial transition, stem cells and beta-catenin. Cells Tissues Organs. 2003;179(1-2):56-65. doi:10.1159/000084509
  8. Lee J, Dedhar S, Kalluri R, Thompson E. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006;172(7):973-981. doi:10.1083/jcb.200601018
  9. Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta. 2007;1773(5):642-652. doi:10.1016/j.bbamcr.2006.07.001
  10. Brockmann C, Huarte J, Dugina V, Challet L, Rey E, Conne B, et al. Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. Biol Reprod. 2011;85(5):1025-1039. doi:10.1095/biolreprod.111.091736
  11. Dugina V, Zwaenepoel I, Gabbiani G, Clement S, Chaponnier C. Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. J Cell Sci. 2009;122(16):2980-2988. doi:10.1242/jcs.041970
  12. Baranwal S, Naydenov N, Harris G, Dugina V, Morgan K, Chaponnier C, Ivanov A. Nonredundant roles of cytoplasmic beta- and gamma-actin isoforms in regulation of epithelial apical junctions. Mol Biol Cell. 2012;23(18):3542-3553. doi:10.1091/mbc.E12-02-0162
  13. Dugina V, Khromova N, Rybko V, Blizniukov O, Shagieva G, Chaponnier C, et al. Tumor promotion by γ and suppression by β non-muscle actin isoforms. Oncotarget. 2015;6(16):14556-14571. doi:10.18632/oncotarget.3989
  14. Gunderson L, Sargent D, Tepper J, Wolmark N, O'Connell M, Begovic M, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol. 2004;22(10):1785-1796. doi:10.1016/S0360-3016(02)02945-0
  15. Jeanes A, Gottardi CJ, Yap AS. Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene. 2008; 27(55):6920-6929. doi:10.1038/onc.2008.343
  16. Anwar S, Wahyono A, Aryandono T, Haryono S. Caveolin-1 in breast cancer: single molecule regulation of multiple key signaling pathways. Asian Pac J Cancer Prev. 2015;16(16):6803-6812. doi:10.7314/APJCP.2015.16.16.6803
  17. Dugina VB, Chipysheva TA, Ermilova VD, Gabbiani D, Chaponnier C, Vasil'ev YuM. Distribution of actin isoforms in normal, dysplastic, and tumorous human breast cells. Arkhiv patologii. 2008;70(2):28-31. (In Russ.)
  18. Dugina VB, Ermilova VD, Chemeris GI, Chipysheva TA. Actins and keratins in the diagnosis of human basal-like breast cancer. Arkhiv patologii. 2010;72(2):12-15. (In Russ.)
  19. Shagieva GS, Domnina LV, Chipysheva TA, Ermilova VD, Chaponnier C, Dugina VB. Actin isoforms and reorganization of adhesion junctions in epithelial-to-mesenchymal transition of cervical carcinoma cells. Biokhimiya. 2012;77(11):1266-1276. (In Russ.) doi:10.1134/S0006297912110053
  20. Dugina V, Alieva I, Khromova N, Kireev I, Gunning P, Kopnin P. Interaction of microtubules with the actin cytoskeleton via cross-talk of EB1-containing +TIPs and γ-actin in epithelial cells. Oncotarget. 2016;Sept24. doi:10.18632/oncotarget.12236

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.